Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares, rose in value on Friday, November 22, with the stock price up by 1.09% to the previous day’s close as strong demand from buyers drove the stock to $3.72.
Actively observing the price movement in the last trading, the stock closed the session at $3.68, falling within a range of $3.645 and $3.81. Referring to stock’s 52-week performance, its high was $5.02, and the low was $1.86. On the whole, MREO has fluctuated by -14.48% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
With the market capitalization of Mereo Biopharma Group Plc ADR currently standing at about $575.60 million, investors are eagerly awaiting this quarter’s results, scheduled for in December.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.37M.
The stock’s technical analysis shows that the price of MREO currently trading nearly -6.17% and -10.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.37, while the 7-day volatility ratio is showing 7.80% which for the 30-day chart, stands at 5.55%. Furthermore, Mereo Biopharma Group Plc ADR (MREO)’s beta value is 0.97, and its average true range (ATR) is 0.23.
A comparison of Mereo Biopharma Group Plc ADR (MREO) with its peers suggests the former has fared considerably weaker in the market. MREO showed an intraday change of 1.09% in last session, and over the past year, it grew by 78.42%%.
Data on historical trading for Mereo Biopharma Group Plc ADR (NASDAQ:MREO) indicates that the trading volumes over the past 10 days have averaged 1.09 and over the past 3 months, they’ve averaged 764.59K. According to company’s latest data on outstanding shares, there are 154.73 million shares outstanding.
Nearly 8.23% of Mereo Biopharma Group Plc ADR’s shares belong to company insiders and institutional investors own 60.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.57 million shares as on 2024-10-31, resulting in a short ratio of 7.45. According to the data, the short interest in Mereo Biopharma Group Plc ADR (MREO) stood at 352.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 4.88 million. The stock has risen by 61.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MREO stock heading into the next quarter.
